Near-Infrared, Light-Triggered, On-Demand Antiinflammatories and Antibiotics Release by Graphene Oxide/Elecrospun PCL Patch for Wound Healing by Mauro, N. et al.
  
C 2019, 5, 63; doi:10.3390/c5040063 www.mdpi.com/journal/carbon 
Article 
Near-Infrared, Light-Triggered, On-Demand Anti-
inflammatories and Antibiotics Release by Graphene 
Oxide/Elecrospun PCL Patch for Wound Healing 
Nicolò Mauro 1,2,* Salvatore Emanuele Drago 1, Gennara Cavallaro 1 and Gaetano Giammona 1 
1 Laboratory of Biocompatible Polymers, Department of “Scienze e Tecnologie Biologiche, Chimiche e 
Farmaceutiche” (STEBICEF), University of Palermo, Via Archirafi, 32 90123 Palermo, Italy 
2 Fondazione Umberto Veronesi, Piazza Velasca 5, 20122 Milano, Italy 
* Correspondence: nicolo.mauro@unipa.it; Tel.: +39 09123891928; Fax: +39 09123891928 
Received: 23 September 2019; Accepted: 19 October 2019; Published: 23 October 2019 
Abstract: Very recently, significant attention has been focused on the adsorption and cell adhesion 
properties of graphene oxide (GO), because it is expected to allow high drug loading and controlled 
drug release, as well as the promotion of cell adhesion and proliferation. This is particularly 
interesting in the promotion of wound healing, where antibiotics and anti-inflammatories should 
be locally released for a prolonged time to allow fibroblast proliferation. Here, we designed an 
implantable patch consisting of poly(caprolactone) electrospun covered with GO, henceforth named 
GO–PCL, endowed with high ibuprofen (5.85 mg cm−2), ketoprofen (0.86 mg cm−2), and vancomycin 
(0.95 mg cm−2) loading, used as anti-inflammatory and antibiotic models respectively, and capable 
of responding to near infrared (NIR)-light stimuli in order to promptly release the payload on-
demand beyond three days. Furthermore, we demonstrated the GO is able to promote fibroblast 
adhesion, a key characteristic to potentially provide wound healing in vivo. 
Keywords: on-demand drug release; graphene oxide; plasma; polycaprolactone; vancomycin; 
wound healing 
 
1. Introduction 
Under certain circumstances, such as burns and chronic skin conditions, wound healing 
processes can be jeopardized by inflammation and infections [1,2]. Regions of avascularization, 
necrosis, prolonged and increased inflammation, and inability of immune-cells to avoid bacterial 
infections are all critical challenges inhibiting the physiologic healing of chronic wounds [1]. In 
particular, intense inflammation affects the expression of metalloproteinase MMPs, thereby reducing 
important mechanisms of wound repair, such as extracellular matrix (ECM) remodeling. 
Furthermore, bacterial infections could lead to biofilm, which further enhances inflammation, 
inhibiting ECM deposition and tissue repair.  
Smart wound bandages should primarily aim to prevent bacterial infection by adequate 
covering of the wound microenvironment from external contaminants. On the other hand, they 
should be able to inhibit tissue hyperinflammation and provide cell proliferation so as to promote 
tissue regeneration [2,3]. Therefore, materials used in the treatment of burn or skin conditions are 
employed as scaffold to host endogenous cells and facilitate their growth in situ, and as 
biodegradable bandage to protect the wound area and simultaneously keep suitable conditions to 
support the healing process. The ideal scaffold is supposed to be biocompatible, preserve water 
content in order to prevent dehydration, and permit oxygenation of the growing tissue without 
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interfering with the wound healing [4,5]. Furthermore, it should display a degradation kinetic 
comparable to the rate of tissue growth, thus promoting a rapid healing process while it degrades [6].  
Taking this in mind, engineered polymeric scaffolds have been recently developed to create 
three-dimensional architecture that can mimic the ECM and allow in situ tissue regeneration. In 
particular, electrospun patches with micro and nanofiber architectures obtained by electrospinning 
of polyesters, such as polylactic acid (PLA) and poly(caprolactone) (PCL), yield to scaffolds able to 
mimic the natural collagen fibers in ECM [2,7]. Because of the crucial role of collagen fibers in 
maintaining the integrity of skin, electrospun polymeric patches are attracting biomimetic materials 
potentially able to provide wound healing in vivo [2,6]. Additionally, electrospinning is a mild 
technique that allows loading of bioactive molecules, such as antibiotics or nonsteroidal anti-
inflammatory drugs, to equip the final patch with additional pharmacological effects useful to 
maintain a suitable environment for skin regeneration [8,9]. Moreover, materials able to release their 
cargo on-demand have attracted interest from scientists, so as to keep the wound healing processes 
for a prolonged time and only if required. Thus, plenty of on-demand release biomaterials were 
prepared involving different mechanisms to trigger drug release, such as stimulus-sensitive 
hydrogels and polymeric drug loaded nanosponges [10–12]. However, a multiple drug loaded and 
bioresorbable patch that possesses on-demand antibiosis and anti-inflammatory abilities still has not 
been achieved, which would have great potential in skin regeneration applications.  
Herein, to address this issue, we report on an effective and industrially scalable approach to 
obtain a composite highly biodegradable patch with near infrared (NIR)-triggered antimicrobial and 
anti-inflammatory properties and cell proliferation ability, so as to promote wound healing through 
graphene oxide (GO) covalently deposited onto a PCL scaffold. Indeed, GO exhibits multifunctional 
properties that are useful in drug delivery applications, including enhancement of drug loading 
owing to the huge surface area and on-demand electrical/near infrared (NIR)-triggered drug release 
in the site of action [13–18]. In addition, GO coating has been proposed as a cell adhesion and 
proliferation promoter though nonspecific interaction with living cells [19,20]. We sought to exploit 
a previously developed hybrid patch consisting of PCL electrospun, an FDA approved material [21], 
covered with GO in order to obtain a composite patch endowed with high nonsteroidal anti-
inflammatory drugs and antibiotics loading capability, and capable of responding to NIR-light 
stimuli in order to promptly release the payload on-demand for a prolonged time. Furthermore, we 
try to demonstrate that GO can promote fibroblast adhesion and proliferation while guaranteeing a 
suitable degradation rate, a characteristic to potentially provide wound healing in vivo. We show 
low-vacuum, plasma-assisted GO covalent deposition as a potential technology for the surface 
functionalization of biomaterials with GO sheets for on-demand antimicrobial and anti-inflammatory 
actions, combined with in situ cell proliferation ability, to promote wound healing in skin conditions. 
2. Materials and Methods 
2.1. Materials  
Poly(caprolactone), dichloromethane (DCM), N,N-dimethylformamide (DMF), and Dulbecco’s 
phosphate buffer solution (DPBS) were purchased from Sigma Aldrich (Milan, Italy). Graphene oxide 
nanosheets (1 nm thickness, 500 nm width) were purchased from ACS Material, LLC, Pasadena, CA, 
U.S.A. O2 (99.5%) and N2 (99.8%) were purchased from Air Liquide Italia Service Srl. Dulbecco’s 
minimum essential medium (DMEM) was purchased from Euroclone. Celltracker green® and 
Celltraker Cy5® 4ꞌ,6-diamidino-2-phenylindole (DAPI) were purchased from Life Technologies 
（Waltham, MA, U.S.A.）. 
Human dermal fibroblast cells (HDFa) (obtained from Life Technologies, Waltham, MA, U.S.A.) 
were maintained in Dulbecco’s modified eagle medium (DMEM) containing 10% (v/v) fetal bovine 
serum (FBS, Euroclone, Milan, Italy), 100 units per mL penicillin G, 100 μg mL−1 streptomycin 
(Euroclone,), and 2 mM L-glutamine (Euroclone, Celbar) at 37 °C, in a humidified atmosphere of 5% 
CO2.  
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2.2. Scaffold Preparation  
PCL were prepared using widespread electrospinning [22,23]. PCL patch (380 mg, ≈ 21 cm2, ≈ 
600 μm thickness) was then placed in a low pressure plasma reactor (FEMTO, Diener Electronic 
Plasma-Surface-Technology, Ebhausen, GmbH) and treated for 10 min: 40 kHz; 1 W; N2 15 sccm; 1.0 
mbar. The activation was carried out using nitrogen plasma. Then, the activated patch was 
immediately soaked in a sealed petri dish containing an aqueous solution of graphene oxide 
nanosheets pH 10 (0.5 mg mL−1). The reaction was maintained at 37 °C for 48 h under continuous 
stirring (150 rpm) in a Benchtop 808C Incubator Orbital Shaker model 420. The scaffolds were finally 
washed-up using milliQ water (5 × 200 mL), washed with water over night (200 mL), and dried (0.1 
Torr). The efficiency of GO conjugation was calculated on a weight basis (3.6% w/w). 
2.3. Attenuated Total Reflectance Infrared Spectroscopy (FTIR-ATR)  
The Fourier transform infrared spectra (FTIR) were recorded in the range of 400–4000 cm−1 with 
32 scans and 4 cm−1 resolution, using an ATR accessory in a Bruker Alpha FTIR spectrometer. 
2.4. X-ray Photoelectron Spectroscopy (XPS)  
The XPS spectra of PCL and GO–PCL were recorded on a PHI 5000 VersaProbeII (ULVAC-PHI, 
Inc, Kanagawa, Japan ); source: Kα, 1486.6 eV; beam: 200 μm, 50 W; time per step: 10 ms; energy step: 
0.10 eV; pass energy: 23.50 eV; analyzer mode: FAT. Both samples were dried under vacuum (0.1 
Torr) for 24 h before the analyses. The carbon (C 1s) line at 284.8 eV was used as reference energy. 
2.5. Scanning Electron Microscopy (SEM)  
Morphological characteristics of GO–PCL were evaluated by a scanning electron microscope 
(FEI ESEM Quanta200, Graz, GmbH) operating at 10 kV. The sample was deposited onto a carbon-
coated steel stub, dried under vacuum (0.1 Torr), and sputter-coated with gold (15 nm thickness) 
prior to microscopy examination.  
2.6. Water Uptake 
Percentage water uptake of scaffolds was determined in water, on scaffolds 800 μm in thickness 
and with a base diameter of 50 mm [24]. All samples were dried to constant weight at 0.1 Torr, before 
being put into a test tube containing 50 mL of milliQ water maintained at 37 °C. The disc was 
retrieved, gently wiped with soft filter paper, and weighed. Maximum water uptake was observed 
after about 4 h. The reported values were the average of 6 experiments with a percent mean variation 
coefficient, CV%, lower than 5%. 
2.7. Degradation Time  
Degradation kinetics was observed by following the weight loss of the scaffolds maintained at 
37 °C in PBS pH 7.4 (50 mL) up to 12 months from incubation [25,26]. All samples were dried to 
constant weight and placed in a test tube containing the degradation medium. The weight loss was 
measured at scheduled time intervals. In particular, the samples were retrieved, gently wiped with 
soft filter paper, and weighed. All experiments were performed in triplicate (n=9, 3 independent 
replicates). In all tests the mean CV% was < 5%. 
2.8. Water Contact Angle Measurement  
The hydrophilicity of electrospun PCL patches was studied by a video contact angle instrument 
(VCA Optima, AST Products, Inc, Billerica, MA, U.S.A.). Deionized water was dropped onto the 
surface of the fibrous scaffold, and an image of the drop was recorded. The VCA Optima software 
was used to calculate the contact angle.  
2.9. Drug Loading and Drug Release Kinetics  
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The PCL-GO patch (1 cm2) was put into a test tube containing an aqueous solution of either 
sodium ketoprofen, sodium ibuprofen, or vancomycin hydrochloride (1.5 mL, 7% w/v), and kept for 
15 hours at 37 °C in an orbital shaker (100 rpm). After that, each patch was washed with ultrapure 
water, and aqueous waste was added to the residual volume of the free drug solution, while patches 
were dried under vacuum (0.75 Torr) for 3 days. To determine the amount of the adsorbed drug, the 
residual drug solution was diluted up to 5 mL, and the amount of free drug was quantified 
spectrophotometrically using calibration curves made of drug standards: λibuprofen = 264; λketoprofen = 
260; λvancomycin = 280. 
For the drug release study, the PCL-GO patch (4.95 cm2: 4.22, 28.72 and 4.66 mg of Ketoprofen, 
Ibuprofen, or Vancomycin, respectively) was placed onto a Franz cell (25mm orifice, 20 mL acceptor 
compartment volume, 4.91 cm2 donor compartment area) donor compartment and fixed at the 
perimeter using an o ring silicon seal. Then, 20 mL of PBS pH 7.4 was added to the acceptor 
compartment, kept at 37 °C under continuous stirring. A quantity of 1 mL of solution was withdrawn 
from the acceptor compartment at scheduled time intervals and replaced with equal amount of fresh 
medium. The amount of drug released was evaluated spectrophotometrically, evaluating the 
absorbance of each sample as above reported, and using the ε obtained from standard solutions of 
the drugs in the same medium. Then, the cumulative release was determined as a function of 
incubation time. In a parallel experiment, the NIR-triggered photothermal drug release was 
evaluated, treating the patch with an 810 nm laser diode (power fitted at 5 W cm−2) for 200 s and 
evaluating the pulsed release over time. The on-demand NIR-triggered release was assessed five 
times to establish the feasibility of a pulsed release over time. Each experiment was carried out in 
triplicate, and the results were in agreement within ±5% standard error.  
2.10. Cell Adhesion Assay  
Cell adhesion and proliferation on the virgin, nitrogen plasma activated and GO functionalized 
patches, namely, PCL, PCL–N2, and GO–PCL, respectively, were evaluated by MTS assay, after 
incubation with human dermal fibroblast cells (HDFa) (Life Technologies) for 24 h. The scaffolds 
were placed at the bottom of a 48-multiwell plate using plate insert (CellCrownTM48, Sigma Aldrich), 
and cells (5 × 104 cells/well) were seeded on scaffolds and grown in DMEM. After 24 h, patches were 
withdrawn, washed twice with DPBS, and placed into clean well plates before performing the MTS 
assay. A fresh MTS solution in DMEM was added to each well (400 μL), and cells were incubated for 
additional 3 h. The absorbance at 492 nm was measured using a microplate reader (Plate Reader 
AF2200, Eppendorf). Seeded cells, as they were, were used for the MTS assay as reference control. 
2.11. Statistical Analysis  
Data are presented as mean ± s.e.m., and p-values were determined using a Siegel–Tukey test 
for single comparisons. Statistical analysis was performed using Statext online software. 
3. Results and Discussion 
3.1. Surface Functionalization of PCL Patch with GO Via Nonthermal Low-Vacuum Nitrogen Plasma  
This work reports the development of an electrospun PCL patch, functionalized with GO via 
nitrogen plasma activation, for the on-demand release of nonsteroidal anti-inflammatory and 
antibiotic drugs by means of NIR-light stimuli. Furthermore, this nanocomposite material could be 
exploited as a wound healing promoter, because of their cell adhesion and proliferation properties 
[23,27].  
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Scheme 1. Synthetic steps involved in the surface functionalization of poly(caprolactone) (PCL) 
microfibers with graphene oxide (GO). 
This patch is designed to be potentially employed as a scaffold for the protract treatment of 
injuries and burns so as to prevent inflammation and bacterial contamination, and provide suitable 
tissue regeneration in vivo. This was accomplished by tuning the electrospun PCL physicochemical 
surface features through low-vacuum nitrogen plasma activation and GO covalent functionalization 
(Scheme 1). In particular, PCL patches (6 μm fiber diameter, surface 2 × 21 cm2, ≈ 600 μm thickness) 
were employed as polymeric scaffold, as they are mechanically robust, biodegradable, and 
biocompatible. The surface functionalization involved two-step tandem reactions. In a first step, PCL 
patches were treated with low-vacuum nitrogen plasma, just enough to activate the microfiber 
surface with amine functions while still preserving the bulk microstructures. In fact, corrosion of the 
polymeric surface could occur, and this might affect the 3D macrostructure of the PCL scaffold. This 
approach has been successfully used for scaffold engineering to provide functionalization of the 
surface with primary amines, even if keeping bulk properties of the virgin polymeric material, and 
also to enhance cell adhesion properties of hydrophobic polymers [22,28–30]. Furthermore, primary 
amines also allow monolayer covalent deposition of GO through the reaction with epoxy groups 
intrinsically contained in GO sheets [31]. GO consists of single graphitic monolayer with randomly 
distributed aromatic regions (sp2 carbon atoms) and oxygenated aliphatic regions (sp3 carbon atoms) 
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containing hydroxyl, epoxy, carbonyl, and carboxyl functional groups. Hence, GO was 
functionalized with aliphatic amines on the PCL surface under slightly basic conditions and without 
perturbing its main structure because of versatile chemistry of epoxy groups [23,32].  
The morphological characterization of the hybrid patch by scanning electron microscopy (SEM) 
revealed that microfibers did not undergo significant corrosion phenomena, but they were stably 
covered by GO sheets (Figure 1 a-a’). Better yet, some GO sheets were able to bridge the gap between 
different microfibers, perhaps due to covalent bonds established with different amine groups (Figure 
1 a’). 
The GO deposition onto the patch surface was confirmed by FTIR spectroscopy. Spectra in the 
region 1800–800 cm−1 are presented in Figure 1b. The vibration band observed at 1749, 1611, and 1667 
cm−1, ascribable to the C=O, asymmetric COO−, and C=C stretching, respectively, indicates the 
presence of GO sheets at the patch surface. In addition, the same modes of vibration of the bulk PCL 
were observed in the GO–PCL, such as those at 2916–2970 and 1724 cm−1, attributable to C–H and 
C=O stretching, pointing out that the functionalization with GO took place at the patch microfiber 
surface. Moreover, it might be noticed that a sharp decrease of the typical bands located at 1040 cm−1, 
corresponding to the epoxy (C–O–C) stretching mode over the basal plane of GO skeleton, hints that 
the functionalization of PCL with GO involved the reaction with epoxy functions. The low amount 
of GO sheets revealed by FTIR spectroscopy and the reaction yield (3.6% on a weight basis) also 
confirmed that GO deposition occurred only at the microfiber surface.  
 
Figure 1. SEM analysis (a–a’) of the GO–PCL sample. Fourier transform infrared (FTIR) spectra of 
PCL (black), GO–PCL (red), and GO (green) in the region within 1800–800 cm−1 (b). X-ray 
photoelectron spectroscopy (XPS) spectrum of GO–PCL: experimental spectrum (black), composite 
spectrum (grey), and deconvolution peaks are showed as colored curves (c). 
The covalent nature of these bonds was also confirmed by means of X-ray photoelectron 
spectroscopy (XPS). Figure 1c shows the typical peaks of the XPS spectrum and the elemental 
composition for the GO–PCL. XPS analysis obtained after nitrogen plasma activation showed 
diagnostic peaks of GO in the C 1s core level. In particular, the characteristic peaks related to the C=C 
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and C=O bonds in GO (284.7 and 287.8 eV, respectively) can be distinguished in the C 1s core level. 
Furthermore, a remarkable peak at 399.2 eV in the N 1s core level region was observed, indicating 
the efficient derivatization of the patch with prim- or sec- amine groups. In agreement with FTIR 
data, this peak entails that the functionalization of the microfibers with GO involved the nucleophilic 
attack of reactive primary amine functions to the epoxy groups of the GO sheets.  
3.2. GO Allows Water Uptake and Accelerates Degradation of the Scaffold  
Plasma-induced covalent GO coating can affect the physicochemical properties of the PCL patch 
in terms of biodegradability and water uptake, as hydroxyl, carboxyl, and amine groups introduced 
at the material/medium interface improve the hydrophilicity of the patch surface. Water uptake is an 
important feature of biomaterials, which are designed to be somehow placed in the body (e.g., 
patches for regenerative applications and implants). This, because of a high water content, reduces 
interfacial tensions between the biomaterial and surrounding tissues, thus limiting inflammation [33].  
The water uptake observed in water for the plasma activated scaffold (PCL–N2) was 5.4 times 
higher than that of the virgin PCL patch (Figure 2a), while the water uptake observed for the GO–
PCL patch was about six times higher, entailing a significant effect of the GO coating on water uptake, 
owing to its high water permeability [34]. 
Another factor that strongly influences the biomaterial/tissue interface is the wettability in 
aqueous media. To optimize the biocompatibility and the adhesion and properties of the patch in 
order to promote wound healing, the rule is “the higher the better” [35]. With this in mind, we 
performed water contact angle measurements for GO–PCL patches and compared these with that of 
the virgin PCL (Figure 2b,c). The contact angle of the bare PCL was beyond 120° (Figure 2b), implying 
a scarce water wettability, whereas the functionalized PCL patch displayed very low values (~35°), 
which indicate high wettability in physiological media (Figure 2c).  
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Figure 2. Water uptake (a) and water contact angle measurements for the virgin PCL (b) and GO–
PCL patches (c). 
These data suggest on the whole that the functionalization of the PCL patch with GO sheets 
improves its surface performance toward physiological interfaces, which it might expect to affect the 
biocompatibility and cell adhesion properties.  
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Figure 3. Degradation kinetics of the GO–PCL patch compared with the virgin PCL sample. 
Water uptake and wettability can also play a part in determining degradation of the PCL patch, 
as it mainly occurs by hydrolysis. Thus, the degradation kinetic of the GO–PCL was assessed and 
compared to that of the bare PCL patch (Figure 3) [36]. It may be noticed that the degradation of the 
functionalized patch is time-dependent and shorter to that observed for the bare patch (~ 12 vs >> 12 
months, respectively). In particular, for the bare PCL patch, only 21% of weight loss was observed 
after 12 months of incubation at 37 °C (Figure 3). The higher degradation rate observed for the 
functionalized patch suggests that GO endows microfibers with hydrophilic groups, which allow 
surface reorientation and subsequent higher water diffusion at the biomaterial/medium interface 
[37]. This is proof that GO functionalization involves the formation of covalent bonds at the PCL 
surface. 
3.3. GO Coating Improves the Drug Loading and can Promote On-Demand Drug Release  
The GO–PCL patch was designed to locally release a controlled amount of nonsteroidal anti-
inflammatory drugs (i.e., ibuprofen and ketoprofen) and antibiotics (vancomycin), which could be 
used as on-demand treatment for burns and skin conditions [38]. This was accomplished by NIR-
light external stimulus, which implies advantages for several reasons including biocompatibility, 
high temporal control, ease of use, and its noninvasive nature. Here, NIR light was absorbed by GO 
sheets at the GO–PCL surface, to be dissipated via vibrational motion affording local heating and, 
consequently, drug release. However, the rule of GO is manifold. Apart from the NIR-triggered on-
demand release, it was employed for its outstanding ability to adsorb high amounts of hydrophobic 
drugs. In fact, GO–PCL was able to load a high amount of ketoprofen, ibuprofen, and vancomycin, 
used as model drugs, by means of simple immersion in drug solution (Table 1). In particular, drug 
loading observed for the GO–PCL patch was about 6.5–3 times higher compared with common 
commercially available patches (Table 1). This could provide suitable treatments for a prolonged 
time.  
Table 1. Drug loading of GO–PCL compared with commercially available patches. 
Sample 
 
Ketoprofena  
(mg/cm2) 
Ibuprofena  
(mg/cm2) 
Vancomycina  
(mg/cm2) 
GO–PCL 0.86 ± 0.01 5.85 ± 0.13 0.95 ± 0.05 
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Keplant® 0.29 ± 0.02 n.a. n.a. 
Ibupas® n.a. 0.89 ± 0.08 n.a. 
a Drug loading obtained by UV spectrophotometry. 
Drug release studies reported in Figure 4 show that GO–PCL slowly released the drug payload 
without hinting to a burst effect, thus suggesting that there is no sponge-like physical absorption of 
drugs into the patch. Indeed, a sharp release of active therapeutics from the surface occurred only 
after NIR light was shined onto the surface. The NIR-triggered on-demand drug release from the 
GO–PCL patch was studied using bicompartmental Franz cells in PBS pH 7.4, applying an 810 nm 
laser diode impulse for 200 s at scheduled time intervals (Figure 4a). An NIR exposure with low 
power density (5 Wcm−2) was selected on the basis of a previously reported study, in order to avoid 
any harmful effects on skin cells [23]. The NIR-triggered drug release profiles were compared with 
those obtained without external stimulus (Figure 4 b–d). GO–PCL released about 5% of its ketoprofen 
payload after 70 h of incubation, while under cyclic NIR-light stimulus it was able to release up to 
23% of ketoprofen within the same time interval (Figure 4b), releasing about 4% of the ketoprofen 
payload whenever it is applied the light irradiation. A similar trend, although more moderate, was 
observed for ibuprofen (Figure 4c).  
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Figure 4. Drug release study of the loaded GO–PCL patches in PBS pH 7.4 after five cycles of near 
infrared (NIR) photo stimulation: each arrow indicates the exposure to an 810 nm laser diode for 200 
s and a power density of 5 Wcm−2. 
A remarkable NIR-light-dependent release was observed for vancomycin (Figure 4d). Whilst no 
vancomycin release was observed without NIR stimulus, GO–PCL released beyond 28% of the 
vancomycin payload over the entire range considered. This could be ascribed to the higher aromatic 
character of vancomycin, which results in the formation of stable π–π stacking interactions with GO. 
Overall, each NIR-light impulse activates the release of about 4–6% of the drug payload, confirming 
that GO coating plays a crucial role in determining a suitable on-demand release in situ.  
3.4. GO can Foster Wound Healing by Improving Cell Adhesion and Proliferation  
Here, GO functionalization onto PCL microfibers was achieved for various reasons. On the one 
hand, if the PCL patch does not have enough available specific surface, it would not be able to load 
a high quantity of drugs to be released in situ. In addition, GO is able to trigger the release of drugs 
by selective NIR photo stimulation by producing local heat (phototherapy), and thus it was selected 
to obtain on-demand release of anti-inflammatory and antibiotic drugs at the wound site. On the 
other hand, GO has been recently studied as a cell adhesion and proliferation promoter owing to 
their hydrophilic and protein adsorption properties, which could be of help to provide wound 
healing during the pharmacological therapy [23,39,40]. 
. 
Figure 5. MTS assay after 24 h of incubation of the scaffolds with HDFa. Cell adhesion values are 
calculated comparing cell viability on each scaffold to that obtained for the free well (positive control). 
Data shown as mean ± s.e.m. (n=6, two independent biological replicates); **P<0.01 (Siegel–Tukey 
test). 
An in vitro model of human fibroblasts (HDFa) was employed, as it is important to understand 
HDFa behavior within the skin in the context of wound healing [41,42]. 
HDFa cells were incubated on the top of the GO–PCL patches for 24 h, and then cell viability 
was quantified by MTS assay and compared to that observed for the bare PCL patch (Figure 5). Cell 
viability tests demonstrated the ability of GO–PCL to promote fibroblasts adhesion and proliferation 
in comparison with the bare patch (Figure 5). HDFa adhered at the GO–PCL surface up to about 80%, 
16% higher than the value observed for the PCL patch (Figure 5). The adhesion factor, expressed as 
the Abs492nm24h,sample/ Abs492nm24h,control ratio, was roughly 1.25 times higher for the GO functionalized 
patch.  
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Given the importance of HDFa in fostering wound healing, one can assume that GO–PCL could 
be employed as a versatile scaffold to simultaneously activate self-repairing mechanisms of tissues 
in vivo, and to provide suitable on-demand anti-inflammatory and antibiotic therapies to avoid 
undesired responses and infections.  
4. Conclusions 
Here, we designed an implantable patch consisting of poly(caprolactone) electrospun covered 
with GO, namely GO–PCL, to allow skin wound healing by combining on-demand release of 
nonsteroidal anti-inflammatory and antibiotic drugs with in situ fibroblast cell recruiting and 
proliferation. The surface covalent functionalization with GO, thanks to its huge surface area and 
outstanding adsorption properties, endows common polymeric patches with high ibuprofen (5.85 
mg cm−2), ketoprofen (0.86 mg cm−2), and vancomycin (0.95 mg cm−2) loading, used as anti-
inflammatory and antibiotic models, respectively. Moreover, the immobilized GO sheets proved 
capable of responding to NIR-light stimuli, in order to promptly release the payload on-demand 
beyond three days. We also demonstrated that GO is able to promote fibroblast adhesion and 
proliferation, a key characteristic to potentially provide wound healing in vivo. Thus, we conclude 
that the functionalization of electrospun polymeric patches with GO described herein is a versatile, 
mild, cost effective, and scalable strategy that can be employed to prepare smart nanocomposite 
patches in the treatment of burns and skin conditions. 
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